Published: Jun, 2018

Currently, the global genome engineering market comprise of some of the well-established players. But the degree of competition is foreseen to rise within the forecast period from 2015 to 2023. This is credited to the emergence of new players in the market. The global genome market is supported highly by the majority of players settled in Western Europe and Americas. Looking at this, there seems to be a rise in research and development activities in China and several other developing nations of Asia Pacific region in order to expand their customer base. Moreover, several biotech and pharmaceutical firms are concentrating on coming up with better services and products, product portfolios, opening more labs for research activities, innovations in various nations to sustain in the competition in the market.

Some of the key players in the market are Horizon Discovery, GenScript USA, and Integrated DNA Technologies. Besides these, Lonza Group, Sangamo Biosciences, New England Biolabs, Sigma-Aldrich Corporation, Transposagen Biopharmaceuticals, and Thermo Fisher Scientific are some more important firms leading the market.

According to Transparency Market Research (TMR), the global genome engineering market is anticipated to expand at a steady CAGR of 14.2% CAGR within the forecast period from 2015 to 2023. In 2015, the market was valued at around worth of US$2.30 bn, which is anticipated to rise around the value of US$7.21 bn by the end of 2023. On the basis of application, the global genome engineering market is dominated by academic segment with highest share of revenues in 2014. The segment is expected to continue its lead in coming years as well. Regionally, North America region is likely to dominate the market with the most lucrative scope of development in forthcoming years. This is attributed to notable increase in research and development activities in genetics sector in the region.

Investments by Pharmaceuticals and Biotechnology to Fuel Market Growth

Pharmaceutical and biotechnology organizations over the globe are gradually realizing the need for advanced technology for diagnosing genetic changes. Thus, there has been a rise in research and development activities, contributing in the increased demand for genome engineering in the market. Various firms are stressing towards cell mutation in order to control cell and hereditary infections. The rising speculations by non-government associations and governments in genome advancements together with the investments by pharmaceutical and biotechnology sector are acting as a catalyst to the global market for genome engineering.

Genome Engineering to Be Beneficial in Curing Terminal Illness as Well

The worldwide utilization of different technologies such as ZNF, CRISPR/Cas9, and TALEN in quality treatment for various genetic issue and terminal ailments will be one of the essential drivers for the development of this market. Gene therapy utilizes RNZ guide and gene alteration for repairing DNA and adjust cells to help cure ailments. These progressions in genome engineering can be utilized to cure sicknesses, for example, cancer, genetic diseases, immunodeficiency, and viral infection.

This analysis is based on a recent market research report by Transparency Market Research, titled, “Genome Engineering Market (Technology - Clustered regularly interspaced short palindromic repeats (CRISPR), Transcription activator-like effector nuclease (TALEN), and Zinc Finger Nuclease (ZFN); Application - Cell Line Engineering, Animal Genome Engineering, and Plant Genome Engineering; End User - Pharmaceutical and Biotechnology Companies, Academics, and Clinical Research Organizations) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 – 2023.”

Global Genome Engineering Market, by Technology

  • Clustered regularly interspaced short palindromic repeats (CRISPR)
  • Transcription activator-like effector nuclease (TALEN)
  • Zinc Finger Nuclease (ZFN)
  • Other Technologies

Global Genome Engineering Market, by Application

  • Overview
  • Cell Line Engineering
  • Animal Genome Engineering
  • Plant Genome Engineering
  • Other Application

Global Genome Engineering Market, by End-User

  • Overview
  • Pharmaceutical and Biotechnology Companies
  • Academics
  • Clinical Research Organizations

Global Genome Engineering Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Rest of Asia Pacific
  • Rest of the World (RoW)
    • Latin America
    • Middle-East & Africa

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

Contact Us

Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453